- Global Pharma News & Resources

Press Releases - 2023-02-06

Date Title Company
06-Feb-2023 Onxeo: Report on the Extraordinary General Meeting of February 6, 2023 Businesswire
06-Feb-2023 IDC MarketScape Names Medidata a Leader in Life Science R&D Risk-Based Monitoring Solutions Vendor Assessment Businesswire
06-Feb-2023 CureVac Announces Proposed Public Offering of Common Shares CureVac
06-Feb-2023 Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
06-Feb-2023 Acticor Biotech Announces the Appointment of Patricia Zilliox to the Board of Directors as an Independent Director Businesswire
06-Feb-2023 SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing SYNLAB AG
06-Feb-2023 SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes SYNLAB AG
06-Feb-2023 Worldwide Demand For Assistive Furniture Is Predicted To Increase At A CAGR Of 6% From 2022 To 2026 MARKITWIRED Latest Market Reports
06-Feb-2023 Qosina Appoints Lee Pochter as Executive Vice President Businesswire
06-Feb-2023 ZS to Acquire Intelligent Study Design Company Businesswire
06-Feb-2023 IgGenix Announces First Close of $40M Series B Financing to Accelerate Lead Antibody Program in Peanut Allergy Businesswire
06-Feb-2023 SDC Announces the Rollout of SDC Capture™ Solution Businesswire
06-Feb-2023 Thompson Street Capital Partners Completes Growth Investment in Sabai Global Businesswire
06-Feb-2023 Anodyne Nanotech, Inc. Appoints Jeff Mihm to its Board of Directors Businesswire
06-Feb-2023 Nutcracker Therapeutics Adds Dr. Thomas J. Dietz to Board of Directors Businesswire
06-Feb-2023 Concerto Biosciences Announces Strategic Business Development Hire Businesswire
06-Feb-2023 Orthopedic Trauma Devices Market is expected to be worth US$ 21.2 billion by 2033 | FMI Analyst MARKITWIRED
06-Feb-2023 Oxford BioDynamics’ Prostate Screening EpiSwitch® Blood Test Significantly Enhances Overall Detection Accuracy For At Risk Men Businesswire
06-Feb-2023 Silence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations Officer Businesswire
06-Feb-2023 GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Businesswire